TNFSF10 and diabetic retinopathy: In a therapeutic perspective, this means that both normalization of the lipid metabolic profile and practices aimed to elevate the levels of TRAIL, both in the general circulation and locally in the retina, might be beneficial in the early onset of DR when the proliferative stage of diabetic retinopathy has not taken place yet.